<?xml version='1.0' encoding='UTF-8' ?>
<ec-patent-document file='EC_SP18073836_20181228.xml' country='EC' doc-number='SP18073836' kind='A' date-published='20181228' lang='ES' date-produced='20190116'>
<bibliographic-data id='bibl' doc-number='SP18073836' country='EC' lang='es'>
<publication-reference><document-id ><country>EC</country><doc-number>SP18073836</doc-number><kind>A</kind><date>20181228</date></document-id></publication-reference>
<classification-ipcr><classification-ipc sequence='1'><section> </section><class> </class><subclass> </subclass><main-group> </main-group><subgroup> </subgroup><edition> </edition><ipc-version-indicator><date> </date></ipc-version-indicator><classification-level>A61K35/12_A61K38/17_A61K39/395_C07K14/705_C07K16/30</classification-level><symbol-position> </symbol-position><classification-value> </classification-value></classification-ipc></classification-ipcr>
<application-reference> <document-id><country>EC</country><doc-number>SENADI201873836</doc-number><date>20181001</date></document-id></application-reference>
<priority-claims>
<priority-claim sequence='1' kind='National'><doc-number>62/317,334</doc-number><date>20160401</date><country>US</country></priority-claim>
</priority-claims>
<parties><applicants>
<applicant sequence='1' designation='all' app-type='applicant'><addressbook><name>Kite Pharma, Inc.</name><address><street>2225 Colorado Avenue, Santa Monica, California 90404 (US).</street><country>US</country></address></addressbook></applicant>
</applicants>
<inventors>
<inventor sequence='1' designation='all'><addressbook><name>ALVAREZ RODRIGUEZ, Ruben</name><address><street>2225 Colorado Avenue, Santa Monica, California 90404 (US).</street><country>US</country></address></addressbook></inventor>
<inventor sequence='2' designation='all'><addressbook><name>WILTZIUS, Jed</name><address><street>2225 Colorado Avenue, Santa Monica, California 90404 (US).</street><country>US</country></address></addressbook></inventor>
</inventors><agents>
<agent sequence='1' rep-type='agent'><addressbook><name>Romoleroux Armijos, María Cecilia </name><address><street>Robles E4-136 y Av. Amazonas, Edif. Proinco Calisto, piso 11, Quito - Ecuador</street><country>EC</country></address></addressbook></agent>
</agents></parties>
<invention-title lang='es'>MOLÉCULAS DE UNIÓN A BCMA Y MÉTODOS DE USO DE LAS MISMAS</invention-title>
</bibliographic-data>
<abstract lang='es'>La invención proporciona anticuerpos, fragmentos de unión a antígeno de ellos, receptores de antígenos quiméricos (CAR), y receptores de células T modificados genéticamente, polinucleótidos que codifican los mismos, y células in vitro que comprenden los mismos. Los polinucleótidos, polipéptidos y células in vitro descritos en la presente se pueden usar en una terapia de células T CAR modificadas genéticamente para el tratamiento de un paciente que sufre de cáncer. En una forma de realización, los polinucleótidos, polipéptidos y células in vitro descritos en la presente se pueden usar para el tratamiento del mieloma múltiple.</abstract>
</ec-patent-document>
